⚠️ PRESCRIPTION MANDATORY
YURPEAK is a Schedule H medication. Valid prescription from a licensed physician is required for purchase. Self-medication is not advised.
YURPEAK 10mg KwikPen (Tirzepatide Injection): Uses, Benefits, Dosage & Where to Buy
Brand: YURPEAK | Manufacturer: Eli Lilly India Pvt. Ltd. | Composition: Tirzepatide 10mg/0.5ml
📦 YURPEAK 10mg KwikPen – At a Glance
| Generic Name: | Tirzepatide |
| Strength: | 10mg per 0.5ml dose |
| Drug Category: | Dual GIP/GLP-1 Receptor Agonist |
| Dosage Form: | Pre-filled Injection Pen |
| Administration: | Subcutaneous, Once Weekly |
| Pack Contents: | 1 KwikPen (4 weekly doses) |
| Storage: | Refrigerate at 2-8°C |
| Rx Status: | Schedule H (Prescription Only) |
🏥 Order Genuine YURPEAK from PowerNosh Pharmacy ✅ Authentic Eli Lilly Product | ✅ Temperature-Controlled Shipping | ✅ Pan-India Delivery
📞 Order Helpline: +91-8003467285 💬 WhatsApp Order: +91-8003467285
YURPEAK is a premium injectable medication containing Tirzepatide, developed and manufactured by Eli Lilly India Pvt. Ltd. – a globally renowned pharmaceutical company with over 140 years of expertise in diabetes care.
Tirzepatide belongs to a revolutionary class of medications known as "twinecretins" – so named because it simultaneously activates two crucial metabolic hormone receptors:
- 🔵 GIP Receptor (Glucose-dependent Insulinotropic Polypeptide)
- 🟢 GLP-1 Receptor (Glucagon-Like Peptide-1)
This innovative dual-agonist approach makes YURPEAK distinctly more effective than traditional single-receptor medications, offering enhanced blood glucose management and substantial body weight reduction.
YURPEAK Product Specifications
| Brand Name | YURPEAK |
| International Name | Tirzepatide |
| Manufacturer | Eli Lilly India Pvt. Ltd. |
| Country of Origin | India (manufactured for Indian market) |
| Regulatory Approval | DCGI Approved, FDA Approved (US) |
| Therapeutic Category | Anti-diabetic / Anti-obesity Agent |
| Pharmacological Class | Dual GIP and GLP-1 Receptor Agonist |
| Available Dosage Strengths | 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg |
💡 Did You Know? YURPEAK represents the next generation of diabetes and obesity treatment. In clinical trials, patients using Tirzepatide achieved blood sugar and weight loss results that were previously considered unattainable with pharmacotherapy alone.
Salt Composition & Formulation Details
YURPEAK 10mg KwikPen Composition
| Component Type | Ingredient Details |
|---|---|
| Active Pharmaceutical Ingredient | Tirzepatide 10mg per 0.5ml injection |
| Excipients (Inactive Ingredients) |
|
| Solution Appearance | Clear to slightly opalescent, colorless to pale yellow liquid |
| Delivery Device | Single-patient-use pre-filled KwikPen |
| Doses Per Pen | 4 doses (each 0.5ml containing 10mg Tirzepatide) |
| Total Volume | 2ml per KwikPen (sufficient for 4 weekly injections) |
⚠️ Critical Safety Notice:
• YURPEAK KwikPen is designed for single-patient use only
• Never share your injection pen with another person, even with a new needle
• Sharing pens can transmit bloodborne infections including Hepatitis and HIV
• Discard pen after 21 days at room temperature or by expiry date
Therapeutic Uses & Approved Indications
YURPEAK (Tirzepatide) has received regulatory approval for the following therapeutic indications:
Primary Indication #1: Type 2 Diabetes Mellitus (T2DM)
✅ Approved Use for Diabetes
YURPEAK is indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 Diabetes Mellitus.
Can be prescribed:
- As standalone therapy when metformin is unsuitable or not tolerated
- In combination with metformin
- In combination with SGLT2 inhibitors (empagliflozin, dapagliflozin, etc.)
- In combination with sulfonylureas
- As add-on to insulin therapy
Primary Indication #2: Chronic Weight Management
✅ Approved Use for Obesity/Overweight
YURPEAK is indicated for chronic weight management in adults with:
- Obesity: Initial BMI of 30 kg/m² or greater, OR
- Overweight with Comorbidities: Initial BMI of 27 kg/m² or greater AND at least one weight-related condition such as:
- Type 2 Diabetes
- Hypertension (high blood pressure)
- Dyslipidemia (abnormal cholesterol)
- Obstructive sleep apnea
- Cardiovascular disease
Off-Label Considerations
While not officially approved for these uses, healthcare providers may consider YURPEAK for:
- 🔬 Non-alcoholic fatty liver disease (NAFLD) – studies ongoing
- 🔬 Polycystic ovary syndrome (PCOS) with insulin resistance
- 🔬 Metabolic syndrome management
❌ YURPEAK is NOT Indicated For: • Type 1 Diabetes Mellitus • Diabetic Ketoacidosis (DKA) • Pediatric patients (under 18 years) • Cosmetic weight loss without medical qualification • Pregnant or breastfeeding women
How YURPEAK Works in Your Body
Understanding the pharmacology of YURPEAK helps appreciate its remarkable effectiveness. Let's explore how Tirzepatide produces its therapeutic benefits.
The Dual Incretin Mechanism
After you eat a meal, your intestines release hormones called incretins that help regulate blood sugar. YURPEAK mimics the action of two key incretins:
| Receptor Target | Physiological Actions | Clinical Benefits |
|---|---|---|
| GLP-1 Receptor (Glucagon-Like Peptide-1) |
|
|
| GIP Receptor (Glucose-dependent Insulinotropic Polypeptide) |
|
|
Why Dual Agonism is Superior
The combination of GIP and GLP-1 receptor activation produces effects greater than either mechanism alone:
🩸 Blood Sugar Control
Synergistic insulin stimulation leads to HbA1c reductions of up to 2.5% – often bringing levels to non-diabetic ranges.
⚖️ Weight Reduction
Combined appetite suppression and metabolic enhancement result in 15-25% body weight loss in clinical trials.
❤️ Cardiovascular Benefits
Improvements in blood pressure, lipids, and inflammatory markers suggest heart-protective effects.
Pharmacokinetic Profile
| Bioavailability | Approximately 80% (subcutaneous) |
| Time to Peak Concentration | 8-72 hours post-injection |
| Half-life | Approximately 5 days (allows once-weekly dosing) |
| Steady State | Achieved after 4 weeks of once-weekly dosing |
| Protein Binding | Approximately 99% (highly bound) |
| Elimination | Metabolic degradation (proteolytic cleavage) |
Clinical Evidence & Effectiveness
YURPEAK (Tirzepatide) has been extensively studied in the SURPASS clinical trial program for diabetes and the SURMOUNT program for obesity. Here's what the research demonstrates:
SURPASS Trials: Diabetes Results
| Trial | Comparison | HbA1c Reduction | Weight Loss |
|---|---|---|---|
| SURPASS-1 | vs Placebo | Up to -2.07% | Up to -9.5 kg |
| SURPASS-2 | vs Semaglutide (Ozempic) | Up to -2.3% (superior) | Up to -12.4 kg (superior) |
| SURPASS-3 | vs Insulin Degludec | Up to -2.37% | Up to -12.9 kg |
| SURPASS-4 | vs Insulin Glargine | Up to -2.58% | Up to -11.7 kg |
| SURPASS-5 | Add-on to Basal Insulin | Up to -2.59% | Up to -10.9 kg |
SURMOUNT Trials: Weight Loss Results
| Trial | Population | Average Weight Loss | Notable Achievement |
|---|---|---|---|
| SURMOUNT-1 | Obesity without diabetes | Up to -22.5% body weight | 1 in 3 patients lost >25% weight |
| SURMOUNT-2 | Obesity with Type 2 Diabetes | Up to -15.7% body weight | Significant HbA1c improvement |
| SURMOUNT-3 | After intensive lifestyle intervention | Additional -18.4% reduction | Sustained weight maintenance |
| SURMOUNT-4 | Long-term maintenance study | Maintained weight loss | Weight regain prevented |
📊 Key Clinical Takeaways: • YURPEAK demonstrated superior efficacy compared to other GLP-1 agonists including semaglutide (Ozempic) • Many patients achieved HbA1c below 5.7% – the non-diabetic threshold • Weight loss was sustained with continued treatment • Benefits were consistent across different patient populations
Dosage Schedule & Titration: YURPEAK 10mg KwikPen
YURPEAK follows a carefully designed dose-escalation protocol to minimize gastrointestinal side effects while achieving optimal therapeutic benefits.
Standard Dosing Protocol
| Treatment Phase | Weekly Dose | Duration | Purpose |
|---|---|---|---|
| Initiation Phase | 2.5mg once weekly | Weeks 1-4 | Initial tolerability; not primary therapeutic dose |
| First Therapeutic Dose | 5mg once weekly | Weeks 5-8 | Beginning of therapeutic effect |
| Dose Escalation 1 | 7.5mg once weekly | Weeks 9-12 | Enhanced glycemic control |
| Dose Escalation 2 ⬆️ Current Product | 10mg once weekly | Weeks 13-16 | Optimal balance of efficacy/tolerability |
| Higher Dose 1 | 12.5mg once weekly | Weeks 17-20 | For patients needing additional control |
| Maximum Dose | 15mg once weekly | Week 21+ | Maximum approved therapeutic dose |
Dosing Principles
- 💉 Administration: Inject once weekly on the same day each week
- 🕐 Timing: Can be taken at any time of day, with or without food
- 🔄 Day Flexibility: Injection day can be changed if at least 72 hours (3 days) elapse between doses
- 📈 Escalation: Increase dose in 2.5mg increments every 4 weeks as tolerated
- 🎯 Goal: Titrate to minimum effective dose that achieves treatment targets
Missed Dose Instructions
| Situation | Action Required |
|---|---|
| Missed dose remembered within 4 days (96 hours) | ✅ Administer the missed dose as soon as possible |
| Missed dose remembered after 4 days | ⏭️ Skip the missed dose; resume on next scheduled day |
| Approaching next scheduled dose | ❌ Never administer two doses within 72 hours |
Dose Adjustments in Special Populations
| Population | Dose Adjustment |
|---|---|
| Elderly patients (≥65 years) | No adjustment; use standard titration with close monitoring |
| Mild-moderate renal impairment | No adjustment required |
| Severe renal impairment (eGFR <30) | Use with caution; limited data available |
| Mild-moderate hepatic impairment | No adjustment required |
| Severe hepatic impairment | Not studied; use with caution |
Injection Technique: Step-by-Step Guide
YURPEAK KwikPen is designed for simple self-administration. Follow these instructions carefully for optimal results.
Pre-Injection Preparation
- 🧼 Wash hands thoroughly with soap and water for at least 20 seconds
- 📅 Check expiry date on the pen – never use expired medication
- 👁️ Inspect the solution through the viewing window:
- ✅ Clear to slightly opalescent
- ✅ Colorless to pale yellow
- ❌ Do NOT use if cloudy, discolored, or contains particles
- 🌡️ Temperature: If refrigerated, allow pen to reach room temperature (about 30 minutes) before injecting
- 📦 Gather supplies:
- YURPEAK KwikPen
- New sterile pen needle
- Alcohol swab
- Sharps disposal container
Approved Injection Sites
| Injection Site | Location Details | Notes |
|---|---|---|
| Abdomen (Preferred) | Front of abdomen, avoiding 5cm around navel | Usually best absorption; most commonly used |
| Thigh | Front or outer aspect of upper thigh | Good alternative site |
| Upper Arm | Back of upper arm (triceps area) | Requires assistance from another person |
🔄 Rotation: Rotate injection sites each week within the same general body area. Do not inject into the exact same spot repeatedly.
Step-by-Step Injection Process
Step 1: Prepare the Pen
- Remove the gray base cap by pulling straight off
- Attach a new pen needle:
- Remove the protective seal from the needle
- Push needle onto pen tip and twist clockwise until snug
- Remove the outer needle cap (save for disposal)
- Remove the inner needle cap (discard)
Step 2: Prepare the Injection Site
- Select an appropriate injection site
- Clean with alcohol swab using circular motion
- Allow to air dry completely (about 10 seconds)
- Do not touch the cleaned area
Step 3: Unlock and Inject
- Unlock the pen by turning the lock ring
- Place pen firmly against skin at 90-degree angle
- Press and HOLD the purple activation button
- Listen for the first click (injection starting)
- Continue holding for a full 10 seconds
- Listen for the second click (injection complete)
- Verify the gray plunger is visible in the window
- Remove pen from skin
Step 4: Post-Injection Care
- Replace the outer needle cap carefully
- Unscrew and dispose of needle in sharps container
- Replace the gray base cap on the pen
- Store pen appropriately
- Record the date, time, and injection site
⚠️ Critical Safety Reminders
- Never share your KwikPen with another person
- Always use a new, sterile needle for each injection
- Never inject through clothing
- Avoid areas with scars, bruises, or skin abnormalities
- Do not inject into hardened or tender areas
- Apply gentle pressure if bleeding occurs (do not rub)
Adverse Effects & Safety Profile
Like all medications, YURPEAK may cause side effects. Understanding what to expect helps you manage them effectively.
Very Common Side Effects (≥10% of patients)
| Side Effect | Incidence | Typical Duration | Management Strategies |
|---|---|---|---|
| Nausea | 12-24% | Usually improves within 2-4 weeks | Eat smaller meals; avoid fatty foods; stay hydrated |
| Diarrhea | 12-17% | Typically resolves within weeks | Stay hydrated; avoid high-fat foods; contact doctor if severe |
| Decreased Appetite | 10-16% | Persistent (therapeutic effect) | Ensure adequate nutrition; eat nutrient-dense foods |
| Vomiting | 5-10% | Usually temporary | Eat bland foods; small frequent meals; seek help if persistent |
| Constipation | 5-9% | Variable | Increase fiber intake; drink more fluids; stay physically active |
| Abdominal Discomfort | 5-8% | Usually temporary | Eat slowly; avoid trigger foods; contact doctor if severe |
Common Side Effects (1-10% of patients)
- 💉 Injection site reactions: Redness, itching, mild swelling at injection site
- 😴 Fatigue: Tiredness or decreased energy
- 🔥 Dyspepsia: Heartburn or indigestion
- 💨 Flatulence: Increased gas
- 🔄 GERD: Gastroesophageal reflux
- 😵 Dizziness: Light-headedness
- 🦰 Hair loss: Mild alopecia (usually temporary)
Serious Adverse Effects (Seek Immediate Medical Attention)
| Serious Event | Warning Signs | Action Required |
|---|---|---|
| Severe Allergic Reaction | Difficulty breathing, swelling of face/lips/tongue, severe rash, rapid heartbeat | 🚨 EMERGENCY – Call 112 or go to nearest hospital |
| Acute Pancreatitis | Severe persistent abdominal pain (may radiate to back), nausea, vomiting | 🚨 Discontinue YURPEAK; seek emergency care |
| Severe Hypoglycemia | Confusion, shakiness, excessive sweating, loss of consciousness | 🚨 Consume fast-acting glucose; seek medical help |
| Gallbladder Problems | Severe right upper abdominal pain, fever, jaundice | 🚨 Seek immediate medical evaluation |
| Kidney Injury | Significant decrease in urination, severe nausea/vomiting causing dehydration | 🚨 Stay hydrated; contact doctor promptly |
| Thyroid Tumors | Lump or swelling in neck, trouble swallowing, hoarseness | 🚨 Discontinue and seek medical evaluation |
Tips to Minimize Side Effects
🌿 Dietary Strategies
- Eat smaller, more frequent meals (5-6 small meals instead of 3 large)
- Avoid high-fat, greasy, and fried foods
- Limit spicy and heavily seasoned foods initially
- Eat slowly and chew food thoroughly
- Stop eating when comfortably satisfied, not stuffed
💧 Hydration & Lifestyle
- Drink plenty of water throughout the day
- Limit carbonated beverages
- Reduce or eliminate alcohol consumption
- Take a short walk after meals to aid digestion
- Get adequate sleep (7-9 hours nightly)
Warnings, Precautions & Special Populations
🔴 Boxed Warning: Thyroid C-Cell Tumors
⚠️ FDA BLACK BOX WARNING
In rodent studies, tirzepatide caused dose-dependent and duration-dependent thyroid C-cell tumors (including medullary thyroid carcinoma). It is unknown whether YURPEAK causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans.
YURPEAK is contraindicated in patients with:
- Personal history of MTC (Medullary Thyroid Carcinoma)
- Family history of MTC
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Precautionary Conditions
| Condition | Risk/Concern | Recommendation |
|---|---|---|
| History of Pancreatitis | Increased risk of recurrence | Use with extreme caution; monitor closely for symptoms |
| Diabetic Retinopathy | Rapid glucose improvement may temporarily worsen | Regular ophthalmologic monitoring; gradual glucose control |
| Gastroparesis | YURPEAK slows gastric emptying further | May not be appropriate; discuss alternatives with doctor |
| Renal Impairment | GI side effects may cause dehydration, worsening kidney function | Ensure adequate hydration; monitor kidney function |
| Gallbladder Disease | Weight loss increases gallstone risk | Monitor for symptoms; consider prophylaxis if needed |
| History of Suicidal Ideation | Monitor for mood/behavior changes | Report any psychological changes promptly |
Special Populations
Pregnancy
Category: Not recommended during pregnancy
Recommendation: Discontinue YURPEAK at least 2 months before planned conception due to long half-life
Note: Weight loss and medications affecting glucose may pose risks to the fetus
Breastfeeding
Status: Unknown if excreted in human breast milk
Recommendation: Weigh benefits vs. risks; consider discontinuing or avoiding breastfeeding
Note: Discuss with healthcare provider
Pediatric Patients
Status: Safety and efficacy not established in patients under 18 years
Recommendation: Not currently approved for pediatric use
Geriatric Patients
Status: No overall differences in safety/efficacy observed in elderly
Recommendation: Use standard dosing; may have increased sensitivity to GI effects
Note: Greater susceptibility to dehydration; ensure adequate fluid intake
Contraindications: Who Should NOT Use YURPEAK
| Absolute Contraindication | Rationale |
|---|---|
| Known hypersensitivity to Tirzepatide | Risk of anaphylaxis or severe allergic reaction |
| Personal history of Medullary Thyroid Carcinoma (MTC) | Thyroid C-cell tumor risk (from animal studies) |
| Family history of MTC | Genetic predisposition to thyroid tumors |
| Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) | High risk for thyroid tumors |
| Type 1 Diabetes Mellitus | Not studied; mechanism not appropriate for T1DM |
| Diabetic Ketoacidosis (DKA) | Requires insulin therapy, not incretin-based drugs |
| Pregnancy (confirmed or planned) | Potential fetal risk; weight loss during pregnancy harmful |
Drug & Food Interactions
Significant Drug Interactions
| Interacting Drug/Class | Effect of Interaction | Clinical Management |
|---|---|---|
| Insulin | Additive hypoglycemic effect; increased risk of low blood sugar | Reduce insulin dose when initiating YURPEAK; monitor glucose closely |
| Sulfonylureas (Glimepiride, Gliclazide, Glipizide) | Increased hypoglycemia risk | Consider reducing sulfonylurea dose; frequent glucose monitoring |
| Oral Contraceptives | Delayed gastric emptying may reduce absorption | Take oral contraceptive 1 hour before YURPEAK OR use non-oral contraception |
| Medications with Narrow Therapeutic Index (Warfarin, Digoxin, Levothyroxine) | Altered absorption kinetics possible | Monitor drug levels/effects; adjust timing if needed |
| Other GLP-1 Receptor Agonists (Semaglutide, Liraglutide, Dulaglutide) | No additional benefit; additive GI side effects | Do NOT combine YURPEAK with other GLP-1 agonists |
Food Interactions
| Food/Substance | Interaction | Recommendation |
|---|---|---|
| Alcohol | May worsen GI side effects; increased hypoglycemia risk | Limit or avoid alcohol consumption |
| High-Fat Meals | May exacerbate nausea and GI symptoms | Prefer low-fat, easily digestible foods, especially initially |
| Caffeine | May increase GI discomfort in some individuals | Moderate intake; observe personal tolerance |
Storage & Handling Guidelines
Proper storage ensures YURPEAK remains effective and safe throughout its use.
Storage Requirements
| Condition | Before First Use | After First Use |
|---|---|---|
| Temperature | Refrigerate at 2°C to 8°C (36°F to 46°F) | Refrigerate at 2°C to 8°C OR Room temperature up to 30°C (86°F) |
| Duration | Until expiry date on package | Use within 21 days if at room temperature |
| Light Protection | Store in original carton | Protect from direct light |
| Freezing | ❄️ NEVER FREEZE – Discard if frozen | |
Additional Storage Guidelines
- 🚗 Travel: Use insulated cooler bag with ice packs (avoid direct contact with ice)
- ☀️ Heat Exposure: Do not leave in car or direct sunlight
- 👶 Safety: Keep out of reach of children
- 🗑️ Disposal: Dispose of used pens and needles in approved sharps container
- ✈️ Air Travel: Carry in hand luggage with supporting prescription; inform security
Signs of Compromised Medication
Do NOT use YURPEAK if:
- ❌ Solution appears cloudy or contains visible particles
- ❌ Color is significantly different (should be colorless to pale yellow)
- ❌ Pen has been frozen (even partially)
- ❌ Expiry date has passed
- ❌ Pen is damaged or dropped
- ❌ More than 21 days since first use at room temperature
✅ PowerNosh Cold Chain Promise: We ship all YURPEAK orders with specialized temperature-controlled packaging. Your medication is protected from heat exposure throughout transit to ensure full potency and safety.
YURPEAK vs Other GLP-1 Medications
How does YURPEAK compare to other diabetes and weight loss medications?
| Feature | YURPEAK (Tirzepatide) | Ozempic (Semaglutide) | Trulicity (Dulaglutide) |
|---|---|---|---|
| Mechanism | Dual GIP + GLP-1 | GLP-1 only | GLP-1 only |
| Frequency | Once weekly | Once weekly | Once weekly |
| Average HbA1c Reduction | Up to 2.5% | Up to 1.8% | Up to 1.5% |
| Average Weight Loss | Up to 22% | Up to 15% | Up to 5% |
| Approved for Obesity | Yes | Yes (as Wegovy) | No |
| Cardiovascular Outcome Data | Ongoing (SURPASS-CVOT) | Positive (PIONEER) | Positive (REWIND) |
| Manufacturer | Eli Lilly | Novo Nordisk | Eli Lilly |
💡 Key Advantage of YURPEAK: The dual GIP/GLP-1 mechanism provides superior blood sugar and weight control compared to single-agonist GLP-1 medications. Head-to-head trials (SURPASS-2) showed YURPEAK outperformed semaglutide for both HbA1c reduction and weight loss.
Why Purchase YURPEAK from PowerNosh Pharmacy?
When it comes to specialty medications like YURPEAK, choosing the right pharmacy is crucial. Here's why thousands of patients trust PowerNosh Pharmacy:
🏆 Our Unmatched Quality Standards
| Quality Aspect | PowerNosh Commitment |
|---|---|
| Product Authenticity | ✅ 100% genuine Eli Lilly products from authorized channels |
| Batch Verification | ✅ Every batch is verified for authenticity before dispatch |
| Cold Chain Logistics | ✅ Temperature-controlled packaging with gel ice packs |
| Expiry Management | ✅ Only fresh stock with adequate shelf life supplied |
| Documentation | ✅ Proper invoice and product documentation with every order |
| Regulatory Compliance | ✅ Licensed pharmacy adhering to all legal requirements |
💰 Competitive Pricing & Value
- ✅ Best-in-market pricing for YURPEAK
- ✅ No hidden charges or surprise fees
- ✅ Special pricing for regular customers
- ✅ Multi-pen discounts available
- ✅ Insurance/reimbursement support documentation
🚚 Reliable Delivery
- ✅ Pan-India delivery coverage
- ✅ Express shipping options available
- ✅ Real-time shipment tracking
- ✅ Discreet packaging for privacy
- ✅ Temperature-controlled transit
🧑⚕️ Expert Pharmaceutical Support
- ✅ Pharmacist consultation available for queries
- ✅ Dosage and administration guidance
- ✅ Side effect management support
- ✅ Reorder reminders to prevent treatment gaps
- ✅ Prescription verification assistance
⭐ What Our Customers Are Saying
⭐⭐⭐⭐⭐ "Genuine product, perfect delivery" "I was worried about ordering expensive medication online, but PowerNosh exceeded expectations. The YURPEAK arrived cold, well-packaged, and exactly as described. The WhatsApp support team answered all my questions promptly. Will definitely reorder." — Rajesh Khanna, Bangalore
⭐⭐⭐⭐⭐ "Finally found a trustworthy supplier" "After a bad experience with another pharmacy, I was hesitant. PowerNosh's pharmacist called to verify my prescription and even explained how to use the pen correctly. The medicine was authentic and helped me achieve my blood sugar goals." — Dr. Meena Sundaram (Patient), Chennai
⭐⭐⭐⭐⭐ "Recommending to all my patients" "As an endocrinologist, I'm particular about where my patients source their medications. PowerNosh has consistently delivered authentic products with proper cold chain. I now recommend them confidently for specialty diabetes medications." — Dr. Vikram Sharma, Diabetologist, Delhi
⭐⭐⭐⭐⭐ "Lost 18 kg in 5 months - genuine product works!" "My doctor prescribed YURPEAK for diabetes and weight management. I've been ordering from PowerNosh for 5 months – always genuine, always timely. I've lost 18 kg and my HbA1c is finally normal. Thank you PowerNosh team!" — Fatima Sheikh, Hyderabad
🏥 Order YURPEAK 10mg KwikPen from PowerNosh ORDER NOW (PRESCRIPTION REQUIRED) → 📞 Order Helpline: +91-8003467285 💬 WhatsApp Order: +91-8003467285 🌐 Visit: www.powernosh.com ✅ Authentic Eli Lilly Product | ✅ Cold Chain Shipping | ✅ Licensed Pharmacy | ✅ Pan-India Delivery
FAQs
1. Yurpeak injection price
The price of Yurpeak injections may vary by pharmacy and location in India. It depends on the strength and local supply. Always check with your pharmacy or online seller for the latest price.
2. Yurpeak Cipla price
Yurpeak by Cipla is priced differently depending on strength. Prices often vary across cities and sellers. For the most accurate Cipla Yurpeak price, check with authorised pharmacies or online platforms
3. Yurpeak 5mg KwikPen
Yurpeak 5mg KwikPen is a lower strength of the pre-filled Tirzepatide injection. It is used similarly but at a smaller dose. A doctor’s prescription is required before use.
4. Yurpeak KwikPen
Yurpeak KwikPen is the pre-filled, disposable injection device containing Tirzepatide for once-weekly use. It’s designed for easy subcutaneous administration and is available in authorised pharmacies with a prescription.
5. Yurpeak 2.5 mg injection
Yurpeak 2.5mg injection is the lowest starting strength of Tirzepatide available in KwikPen. It is typically used to begin treatment before increasing to higher doses under medical supervision.
6. Yurpeak 2.5mg price
The price of Yurpeak 2.5mg varies across pharmacies and regions in India. Confirm the current rate with your local pharmacy or authorised online seller.
7. Yurpeak 10 Mg
Yurpeak 10mg is a higher-strength Tirzepatide injection used once weekly as prescribed by your doctor. Like other strengths, it’s available in KwikPen form and requires a prescription. Prices vary by seller.
8. Which tablet is best for sugar?
There is no single best tablet; the right medicine depends on your health and your doctor’s advice.
9. How much tirzepatide should I take for weight loss?
The dose is decided by a doctor and is usually increased gradually; do not self-medicate.
10 What is the cost of tirzepatide in India?
The cost varies by brand, strength, and pharmacy; check with an authorised seller for the latest price.
11. What are glucagon tablets used for?
They are used to treat severe low blood sugar by quickly raising glucose levels.
12. Why does YURPEAK come in different strengths?
YURPEAK is available in six strengths (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg) to allow gradual dose escalation. Treatment starts at the lowest dose (2.5mg) and increases every 4 weeks. This gradual approach minimizes gastrointestinal side effects while achieving optimal therapeutic benefit.
